Kishimoto Takashi Kei's Form 4 filing
Cartesian Therapeutics, Inc. (RNAC) · filed Jan 6, 2023
- Accession no.
- 0001453687-23-000033
- Filed
- Jan 6, 2023
- Trade date
- Jan 4-5, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $11.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kishimoto Takashi KeiCIK 0001676930 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Common Stock | SSaleDisposed | −6,381 | $1.13 | −$7,210.53 | 367,719 | Direct | |
| Jan 4, 2023 | Common Stock | SSaleDisposed | −11 | $1.15 | −$12.65 | 367,708 | Direct | |
| Jan 5, 2023 | Common Stock | SSaleDisposed | −3,372 | $1.13 | −$3,810.36 | 364,336 | Direct | |
| Jan 5, 2023 | Common Stock | SSaleDisposed | −20 | $1.11 | −$22.2 | 364,316 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.